India, Sept. 23 -- Artificial intelligence (AI) is changing life sciences from drug discovery and clinical development to manufacturing, diagnostics and drug-safety monitoring. Yet the sector's workforce challenge will not be solved simply by adding a generic AI course to a science degree. Life-sciences professionals need dual fluency: enough biology and regulatory understanding to frame the right problem, and enough data and AI literacy to evaluate whether a system is reliable, safe and useful. This matters because life-sciences AI operates in regulated settings, where errors can affect patients, product quality, scientific integrity, commercial decisions and public confidence at scale.

India already has building blocks. The IndiaAI Mis...